fda warning bpc 157 not approved peptide safety FDA's Overreach on Compounded Peptides FDA panel narrowly backs unapproved

doi:10.1111/j.1365-2249.1992.tb06880.x 20Hooper M, Hudson P, Porter F, et al

It was designed to provide many of the same benefits as IGF-1 itself, including: Enhanced muscle recovery and preservation Fat-burning and promotion of lean body mass Anti-aging action The chemical structure of IGF-1 LR3 gives it a prolonged half-life, leading researchers to question the appropriate IGF-1 LR3 dosage for their next study

AOD-9604 has weak efficacy data

Changing the Focus: The Pernicious Anaemia Societys Work Recognising the limitations of regulatory reclassification, the Pernicious Anaemia Society (PAS) is directing their efforts into three crucial areas to dramatically improve the quality of care for patients across the UK